Company presentation
Teva hopes to launch migraine drug as soon as September | Reuters
Farmaceútica Teva: Noticias de hoy | Europa Press
Teva's proposed opioid settlement could cost drugmaker pennies on the dollar | Reuters
Immunogenicity : Pharmaceuticals : All
Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Placera
January 2017 – GlobalStockPicking.com
Oasmia Pharmaceutical — An appealing metamorphosis - Edison Group
Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe | Business Wire
TEVA Pharmaceuticals Spain - Ya no queda nada para la entrada de un nuevo año cargado de proyectos e ilusión para aportar todo lo que podamos a que los pacientes tengan días
Investment Portfolios
Neuraxpharm avanza en Polonia con la adquisición de Glenmark | PlantaDoce
KEY EVENTS & TRENDS
Avanza Bank – GlobalStockPicking.com
Teva Announces New Organization Structure and Leadership Changes | Placera
Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe | Business Wire
All news articles for December 2018
Israel's Teva Pharm to raise $5 billion in debt securities | Reuters
Ediciones VR - Teva Pharmaceuticals avanza con Cinqaero
Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe - PharmiWeb.com
KEY EVENTS & TRENDS
Annual general meeting 2022
El Covid-19 hoy: Cuba avanza en pruebas de vacuna para niños; Vacunas de AstraZeneca y Pfizer disminuyen protección después de seis meses; Vacuna de refuerzo de Johnson & Johnson aumenta respuesta inmunológica -
